Cefoxitin Sodium Injection Market

Cefoxitin sodium for injection is a white or off-white powder with a special smell. Cefoxitin sodium is used clinically for respiratory infections.Since the global outbreak of COVID-19, these drugs have also entered a stage of shortage .

Cefoxitin Sodium Injection Market contains market size and forecasts of Cefoxitin Sodium Injection in global, including the following market information:

• Global Cefoxitin Sodium Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Cefoxitin Sodium Injection Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Cefoxitin Sodium Injection companies in 2021 (%)

The global Cefoxitin Sodium Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

1g/20ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cefoxitin Sodium Injection include Apotex, Fresenius Kabi, Hikma, Sagent, WG Critical Care, B Braun, Teva, Pfizer and Shenzhen Zhijun Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cefoxitin Sodium Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cefoxitin Sodium Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cefoxitin Sodium Injection Market Segment Percentages, by Type, 2021 (%)

• 1g/20ml
• 2g/40ml
• 10g/200ml

Global Cefoxitin Sodium Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cefoxitin Sodium Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Cefoxitin Sodium Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cefoxitin Sodium Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Cefoxitin Sodium Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Cefoxitin Sodium Injection revenues share in global market, 2021 (%)
• Key companies Cefoxitin Sodium Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Cefoxitin Sodium Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Apotex
• Fresenius Kabi
• Hikma
• Sagent
• WG Critical Care
• B Braun
• Teva
• Pfizer
• Shenzhen Zhijun Pharmaceutical
• Luoxin Group
• Zhendong Group
• Lijian Pharma
• Qilu Pharmaceutical